Alaunos Therapeutics TCRT
NASDAQ TCRT
$0.82 -0.08 (-8.89%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alaunos Therapeutics (TCRT) Return on Capital Employed [ROCE] (2010 - 2026)

Updated

Alaunos Therapeutics (TCRT) posted Return on Capital Employed [ROCE] of -485.70% for Q2 2026, down 314.21 percentage points from -171.49% a year earlier and down 259.13 percentage points from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Return on Capital Employed [ROCE] (2010 - 2026) Analysis & Trends

For FY2025, Alaunos Therapeutics' Return on Capital Employed [ROCE] came in at -206.35%, down 106.45 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for three consecutive years, with a five-year change of -132.87 percentage points (FY2020 to FY2025).
  • In prior years, Alaunos Therapeutics' Return on Capital Employed [ROCE] was -99.90% in FY2024 (-0.98 pp), -98.91% in FY2023 (-35.93 pp), -62.99% in FY2022 (+11.18 pp) and -74.16% in FY2021 (-0.68 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2010.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in six of the last eight quarters, with an average year-over-year change of +44.17 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2025, with a gain of 267.14 percentage points; the weakest was Q1 2024, with a drop of 355.79 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -226.56% (Q1 2026), -166.86% (Q4 2025) and -123.11% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Alaunos Therapeutics 2.04 Mn -1.76 Mn - -485.70%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -485.70%
Mar 31, 2026 -226.56%
Dec 31, 2025 -166.86%
Sep 30, 2025 -123.11%
Jun 30, 2025 -171.49%
Mar 31, 2025 -302.65%
Dec 31, 2024 -195.61%
Sep 30, 2024 -365.18%
Jun 30, 2024 -438.62%
Mar 31, 2024 -445.63%
Dec 31, 2023 -288.07%
Sep 30, 2023 -183.29%
Jun 30, 2023 -103.64%
Mar 31, 2023 -89.84%
Dec 31, 2022 -83.63%
Sep 30, 2022 -99.64%
Jun 30, 2022 -98.06%
Mar 31, 2022 -94.73%
Dec 31, 2021 -87.85%
Sep 30, 2021 -108.75%
API Access

Alaunos Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TCRT&period=max&api_key=YOUR_API_KEY